FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK53618

Market Closed - Börse Stuttgart 11:41:49 2024-07-03 am EDT
0.17 EUR 0.00% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-18.18%
1 month-98.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-03 0.18 +5.88%
24-07-02 0.17 -5.56%
24-07-01 0.18 -18.18%
24-06-28 0.22 -21.43%
24-06-27 0.28 +7.69%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 11:41 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5361
ISINDE000JK53618
Date issued 2024-03-27
Strike 35.25 $
Maturity Unlimited
Parity 23.9 : 1
Emission price 10.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 27.76
Lowest since issue 0.17
Spread 0.03
Spread %13.04%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
39.82 USD
Average target price
49.93 USD
Spread / Average Target
+25.40%
Consensus